Optimized Vaccine Development and Manufacturing: A Technology Overview
The replacement of a IgG ELISA assay with an SPR-based test can shorten the production workflow by one day.
An Improved Manufacturing Process for a Recombinant Polyprotein Vaccine
The recombinant approach lends itself to the production of an inexpensive and effective vaccine at large scale.
Strategies to Improve Vaccines for the Neonate
Potential interference with maternally-derived antibodies makes most vaccines less effective in the neonate.
Recombinant Vaccine Production in Yeast
Human HBV can be grouped into eight genotypes, which differ by at least 8%.
Needle-Free Methods of Vaccination
Microstructured transdermal systems can deliver a vaccine in close proximity to the antigen-presenting cells in the epidermis.